Skip to main content
. 2021 Mar 1;13:2083–2094. doi: 10.2147/CMAR.S296020

Table 2.

Comparison of Characteristics of the Primary and Validation Sets (%)

Characteristics All Patients Primary Set Validation Set P value
Patients 897 598 299
Age 0.824
 <50 81(9.0) 54 (9.0) 27 (9.0)
 50–60 277(30.9) 192 (32.1) 85 (28.4)
 60–70 285(31.8) 186 (31.1) 99 (33.1)
 70–80 169(18.8) 112 (18.8) 57(19.1)
 >80 85(9.5) 54 (9.0) 31,910.4)
Race 0.389
 White 534(59.5) 362 (60.5) 172 (57.5)
 Black 168(18.7) 114 (19.1) 54(18.1)
 Other✱✱ 195(21.7) 122 (20.4) 73 (24.4)
Sex 0.730
 Female 192(21.4) 126 (21.1) 66 (22.1)
 Male 705(78.6) 472 (78.9) 233 (77.9)
Edmonson-Steiner classification 0.921
 Unknown 583(65.0) 387 (64.7) 196 (65.6)
 I 57(6.4) 38 (6.4) 19 (6.4)
 II 127(14.2) 82 (13.7) 45 (15.1)
 III 120(13.4) 84(14) 36(12.0)
 IV 10(1.1) 7(1.2) 3(1.0)
T stage 0.889
 T1 236(26.3) 156(26.1) 80(26.8)
 T2 114(12.7) 79(13.2) 35(11.7)
 T3 408(45.5) 273(45.7) 135(45.2)
 T4 139(15.5) 90 (15.1) 49(16.4)
N stage 0.660
 N0 679(75.7) 450 (75.3) 229(76.6)
 N1 218(24.3) 148 (24.7) 70(23.4)
Bone metastasis 0.949
 None 754(84.1) 503 (84.1) 251(83.9)
 Yes 143(15.9) 95 (15.9) 48(16.1)
Brain metastasis 1
 None 879(98.0) 586 (98.0) 293(98.0)
 Yes 18(0.2) 12 (0.02) 6(0.02)
Intrahepatic metastasis 0.397
 None 821(91.5) 544 (91.0) 277(92.6)
 Yes 76(8.5) 54 (9.0) 22(7.4)
AFP 0.219
 Unknown 121(13.5) 89 (14.9) 32(10.7)
 Elevated 680(75.8) 447 (74.7) 233(77.9)
 Normal 96(10.7) 62 (10.4) 34(11.4)
Insurance status 0.962
 Uninsured 367(40.9) 245 (41.0) 122(40.8)
 Insured 530(59.1) 353 (59.0) 177(59.2)
Marital status 0.129
 Unmarried 401(44.7) 278 (46.5) 123(41.1)
 Married 496(55.3) 320 (53.5) 176(58.9)

Note: ✱✱Indicates American Indian/AK Native, Asian/Pacific Islander, and unknown.

Abbreviation: AFP, alpha fetoprotein.